EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Precision oncology: Using cancer genomics for targeted therapy advancements

Cigir Biray Avci, Bakiye Goker Bagca, Behrouz Shademan, Leila Sabour Takanlou, Maryam Sabour Takanlou, Alireza Nourazarian

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-02 · 1880 (1) · 189250

DOI: 10.1016/j.bbcan.2024.189250 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-02. Verfasst von Cigir Biray Avci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Genomics, Molecular Targeted Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer genomics plays a crucial role in oncology by enhancing our understanding of how genes drive cancer and facilitating the development of improved treatments. This field meticulously examines various cancers' genetic makeup through various methodologies, leading to groundbreaking discoveries. Innovative tools such as rapid gene sequencing, single-cell studies, spatial gene mapping, epigenetic analysis, liquid biopsies, and computational modeling have significantly progressed the field. These techniques uncover genetic alterations, tumor heterogeneity, and the evolutionary dynamics of cancers. Genetic abnormalities and molecular markers that initiate and propagate distinct cancer types are classified according to tumor type. The integration of precision medicine with cancer genomics emphasizes the significance of utilizing genetic data in treatment decision-making, enabling personalized care and enhancing patient outcomes. Critical topics in cancer genomics encompass tumor diversity, alterations in non-coding DNA, epigenetic modifications, cancer-specific proteins, metabolic changes, and the impact of inherited genes on cancer risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNeoplasmsGenomicsMolecular Targeted TherapyMedical OncologyHumansBiomarkers, TumorEpigenesis, Genetic

Stichwörter der Autor:innen

Cаnсer genomiсsGenomiс alterаtionsIntegrаtive genomiсsPreсision onсologyTherарeutiс tаrgets

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Adnan Menderes University, Aydın, Turkey.
  • Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran. Electronic address: noorazarian_a@khoyums.ac.ir.

Zitieren

APA

Avci, C. B., Bagca, B. G., Shademan, B., Takanlou, L. S., Takanlou, M. S., & Nourazarian, A. (2025). Precision oncology: Using cancer genomics for targeted therapy advancements. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(1), 189250. https://doi.org/10.1016/j.bbcan.2024.189250

Vancouver

Avci CB, Bagca BG, Shademan B, Takanlou LS, Takanlou MS, Nourazarian A. Precision oncology: Using cancer genomics for targeted therapy advancements. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(1):189250. doi:10.1016/j.bbcan.2024.189250

BibTeX
@article{Avci2025,
  author = {Avci, Cigir Biray and Bagca, Bakiye Goker and Shademan, Behrouz and Takanlou, Leila Sabour and Takanlou, Maryam Sabour and Nourazarian, Alireza},
  title = {Precision oncology: Using cancer genomics for targeted therapy advancements},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  volume = {1880},
  number = {1},
  pages = {189250},
  doi = {10.1016/j.bbcan.2024.189250}
}
Kostenlos starten →